TLR4 and ulcerative colitis: Meanwhile, Cur supramolecular nanoparticles inhibit inflammation via the TLR4/NF-κB signaling pathway, mitigate oxidative damage by influencing Nrf2/HO-1 signaling, promote macrophage reprogramming, and accelerate the repair caused by ulcerative colitis [49].